Sustained virological response by direct-acting antivirals reduces the recurrence risk of hepatitis C-related hepatocellular carcinoma after curative treatment

The present study aimed to assess the suppressive effect of direct-acting antivirals (DAAs) on hepatocellular carcinoma (HCC) recurrence following curative treatment, particularly compared with interferon (IFN)-based therapy. Among 117 curative cases of HCV-related initial HCC between 2006 and 2017...

Descripción completa

Detalles Bibliográficos
Autores principales: Imai, Kenji, Takai, Koji, Hanai, Tatsunori, Suetsugu, Atsushi, Shiraki, Makoto, Shimizu, Masahito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6951252/
https://www.ncbi.nlm.nih.gov/pubmed/31929880
http://dx.doi.org/10.3892/mco.2019.1956

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6951252/
https://www.ncbi.nlm.nih.gov/pubmed/31929880
http://dx.doi.org/10.3892/mco.2019.1956

Ejemplares similares